Trial Outcomes & Findings for Using Stories to Address Disparities in Hypertension (NCT NCT01276197)

NCT ID: NCT01276197

Last Updated: 2016-12-02

Results Overview

Systolic Bp measurement at 6-month follow-up; we modeled the impact of Intervention assignment on SBP, adjusting for Baseline. Thus, baseline SBP was collected but not used as outcome; Baseline SBP us used as a covariate.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

618 participants

Primary outcome timeframe

6 months after intervention

Results posted on

2016-12-02

Participant Flow

Participant milestones

Participant milestones
Measure
Arm 1: Story-Telling DVD
Participant will receive a DVD with informational and story-telling components Story-Telling DVD: DVD will contain both informational and story-telling components.
Arm 2: Non-Storytelling DVD
Participant will receive an informational DVD Non-Storytelling DVD: DVD will contain only informational component.
Overall Study
STARTED
308
310
Overall Study
COMPLETED
200
200
Overall Study
NOT COMPLETED
108
110

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Using Stories to Address Disparities in Hypertension

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Arm 1: Story-Telling DVD
n=308 Participants
Participant will receive a DVD with informational and story-telling components Story-Telling DVD: DVD will contain both informational and story-telling components.
Arm 2: Non-Storytelling DVD
n=310 Participants
Participant will receive an informational DVD Non-Storytelling DVD: DVD will contain only informational component.
Total
n=618 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
190 Participants
n=5 Participants
186 Participants
n=7 Participants
376 Participants
n=5 Participants
Age, Categorical
>=65 years
118 Participants
n=5 Participants
124 Participants
n=7 Participants
242 Participants
n=5 Participants
Sex: Female, Male
Female
26 Participants
n=5 Participants
25 Participants
n=7 Participants
51 Participants
n=5 Participants
Sex: Female, Male
Male
282 Participants
n=5 Participants
285 Participants
n=7 Participants
567 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
308 Participants
n=5 Participants
310 Participants
n=7 Participants
618 Participants
n=5 Participants
Race (NIH/OMB)
White
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants

PRIMARY outcome

Timeframe: 6 months after intervention

Population: Our analyses was completed with those who completed follow-up visit and varies from participant flow as we are not able to include those lost to follow-up.

Systolic Bp measurement at 6-month follow-up; we modeled the impact of Intervention assignment on SBP, adjusting for Baseline. Thus, baseline SBP was collected but not used as outcome; Baseline SBP us used as a covariate.

Outcome measures

Outcome measures
Measure
Arm 1: Story-Telling DVD
n=264 Participants
Participant will receive a DVD with informational and story-telling components Story-Telling DVD: DVD will contain both informational and story-telling components.
Arm 2: Non-Storytelling DVD
n=270 Participants
Participant will receive an informational DVD Non-Storytelling DVD: DVD will contain only informational component.
Systolic BP at Follow-up
137.9 mmHg
Standard Deviation 18.4
141.2 mmHg
Standard Deviation 17.8

PRIMARY outcome

Timeframe: 6-month following intervention

Participants BP measurement at 6-month follow-up

Outcome measures

Outcome measures
Measure
Arm 1: Story-Telling DVD
n=264 Participants
Participant will receive a DVD with informational and story-telling components Story-Telling DVD: DVD will contain both informational and story-telling components.
Arm 2: Non-Storytelling DVD
n=270 Participants
Participant will receive an informational DVD Non-Storytelling DVD: DVD will contain only informational component.
Diastolic BP Measurement at Follow-up
80.1 mmHg
Standard Deviation 13.0
81.9 mmHg
Standard Deviation 13.1

Adverse Events

Arm 1: Story-Telling DVD

Serious events: 12 serious events
Other events: 0 other events
Deaths: 0 deaths

Arm 2: Non-Storytelling DVD

Serious events: 10 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Arm 1: Story-Telling DVD
n=308 participants at risk
Participant will receive a DVD with informational and story-telling components Story-Telling DVD: DVD will contain both informational and story-telling components.
Arm 2: Non-Storytelling DVD
n=310 participants at risk
Participant will receive an informational DVD Non-Storytelling DVD: DVD will contain only informational component.
Congenital, familial and genetic disorders
Death
0.65%
2/308 • Number of events 2
0.65%
2/310 • Number of events 2
Cardiac disorders
Hospitalization
3.2%
10/308 • Number of events 10
2.6%
8/310 • Number of events 8

Other adverse events

Adverse event data not reported

Additional Information

Dr. Thomas K. Houston

CHOIR

Phone: 781-687-2884

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place